Learn more

WOOGENE B&G CO LTD

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    136,173
  • Filing trend
    ⇧ 100.0%
About

WOOGENE B&G CO LTD has a total of 12 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, Brazil and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and basic materials chemistry are PHYLAXIA OLTOANYAGTERMELOE, NORDISK DROGE & KEMIKALIE and KBNP INC.

Patent filings in countries

World map showing WOOGENE B&G CO LTDs patent filings in countries

Patent filings per year

Chart showing WOOGENE B&G CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Jae Ku 6
#2 Kim Tae Wan 5
#3 Kim Min Ju 4
#4 Kim Dong Wook 4
#5 Kim Cheol 4
#6 Kim Seung Min 4
#7 Jang Hyun 4
#8 Kang Seog Jin 4
#9 Park Young Bin 3
#10 Hwang Yeong Min 3

Latest patents

Publication Filing date Title
KR102058133B1 Composition for enhancing immune activity capable of improving of solubility of antibiotics in mixed formulation and use thereof
KR20200055972A Vaccine composition for treating or preventing swine dusentery
KR20180128347A Mass culture method for antimicrobial strain
KR101865053B1 Composition for Preventing Scuticociliates comprising Photobactin and method for Preventing Scuticociliates in fish using the same
KR20190084432A Composition for disinfection and acaricide, and method for controlling of red mite using the same
KR101922414B1 Enterotoxigenic Escherichia coli that surface displaying alpha toxin of Clostridium perfringens
KR101743457B1 Insect controlling agents for aquatic insect comprising Bacillus thuringiensis for and Photohabdus asymbiotica, and method for controlling using the same
KR101818901B1 Inactivated vaccine composition of Actinobacillus pleuroneumoniae inactivated bacterin and N or C fragments of Actinobacillus pleuroneumniae ApxIA, ApxIIA, ApxIIIA inactivated toxin
KR101694676B1 Streptococcus equi strain and the vaccine composition comprising the same
KR101654023B1 Live vaccine composition, inactivated vaccine composition and oral vaccine comprising the same from currently isolated attenuated porcine epidemic diarrhea virus